BIRK
Birkenstock Holding plc
BIRK has the edge over LCID overall, supported by lower modeled downside.
LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BIRK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Stable |
BIRK's revenue and profitability are currently healthy, and its cash flow and balance sheet are stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BIRK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $34.66 | -2.9% |
| Current | 17x | $35.70 | — |
| Fair | 32x | $64.55 | +81% |
| Expensive | 96x | $195 | +447% |
Historical ranges are pointers, not guarantees.
BIRK's PE is 17x, but its earnings don't support one, so it isn't a reliable read right now.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
BIRK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for BIRK, with profitability holding steady.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BIRK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $2.04 | +12% |
| Q1 2026 | $2.13 | +42% |
| Q4 2025 | $2.26 | +74% |
| Q3 2025 | $2.08 | +84% |
| Q2 2025 | $1.82 | +176% |
| Q1 2025 | $1.50 | +154% |
| Q4 2024 | $1.30 | +177% |
| Q3 2024 | $1.13 | +146% |
BIRK has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
BIRK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $812.6M | +15% |
| Q1 2026 | $698.2M | +9.4% |
| Q4 2025 | $446.5M | +11% |
| Q3 2025 | $584.7M | +15% |
| Q2 2025 | $705.5M | +12% |
| Q1 2025 | $638M | +19% |
| Q4 2024 | $401.8M | +19% |
| Q3 2024 | $506.3M | +22% |
BIRK's revenue has grown year over year for 14 quarters in a row: $813M last quarter, up 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 29% | -2.4 points |
| Q1 2026 | 26% | -4.3 points |
| Q4 2025 | 19% | +1.8 points |
| Q3 2025 | 21% | -0.1 points |
| Q2 2025 | 31% | +3.6 points |
| Q1 2025 | 31% | +3 points |
| Q4 2024 | 18% | +6 points |
| Q3 2024 | 21% | +15 points |
BIRK has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over BIRK on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
BIRK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $224M | -16% |
| Q1 2026 | $2.2M | +$43.5M |
| Q4 2025 | -$72.7M | -$43.4M |
| Q3 2025 | $145.5M | +3.4% |
| Q2 2025 | $266.7M | -10% |
| Q1 2025 | -$41.3M | -212% |
| Q4 2024 | -$29.2M | +$41.4M |
| Q3 2024 | $140.8M | +32% |
BIRK has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
BIRK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.3% | -2.4M shares |
| 1 year | -2.7% | -5M shares |
| 3 years | -0.7% | -1.2M shares |
BIRK has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $260.5M |
| Q1 2026 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
BIRK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 1.8x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.2x | Healthy |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | 1.6x | Healthy |
| Q4 2024 | 1.6x | Healthy |
| Q3 2024 | 1.6x | Healthy |
BIRK's net debt is about 1.8 years of its operating earnings (EBITDA), up from 1.4 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BIRK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.6 | Neutral |
| Stochastic | 39.8 | Neutral |
BIRK's weekly RSI is 48 (neutral) and its Stochastic is 40 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BIRK PE vs Consumer Cyclical Sector
| Metric | BIRK | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 3.1% below |
| PE % | 20 | 29 | 9 pts below |
BIRK is trading at 17x earnings, in line with the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
BIRK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.2 | 4.4% above |
| 20 week MA | $36.7 | 2.6% below |
| 50 week MA | $38.8 | 8.1% below |
| 100 week MA | $44.3 | 19% below |
BIRK has stronger trend alignment. BIRK is above 1 of 4 weekly averages versus LCID above 0 of 5.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
BIRK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $36.4 | $48.7 | +34% |
| 2024 | $48.7 | $59.1 | +21% |
| 2025 | $59.1 | $42.4 | -28% |
| 2026 YTD | $42.4 | $35.7 | -16% |
BIRK has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.